Table 2.
Main fatty acids (≥0.5%) from total lipids (weight %) of serum (a) and liver (b) of animals after 8 weeks of feeding a diet containing PO, PO+ACN, RO or RO+ACN, respectively.
| Fatty acids | PO |
RO |
P valuea |
||||
|---|---|---|---|---|---|---|---|
| PO | PO+ACN | RO | RO+ACN | Lipid | ACN | L×ACN | |
| (a) Serum | |||||||
| 14:0 | 0.8±0.2 | 0.8±0.2 | 0.6±0.1 | 0.6±0.2 | 0.002 | NS | NS |
| 16:0 | 25.7±4.1 | 25.3±4.9 | 22.7±2.1 | 23.0±2.7 | 0.037 | NS | NS |
| 16:1 n7 | 4.3±2.2 | 4.0±1.1 | 3.8±1.5 | 4.5±2.2 | NS | NS | NS |
| 18:0 | 12.1±4.0 | 12.5±2.4 | 11.7±1.4 | 11.3±1.1 | NS | NS | NS |
| 18:1b | 21.9±5.9 | 21.2±3.6 | 16.5±2.4 | 17.5±2.9 | 0.003 | NS | NS |
| 18:2 n6 | 9.8±4.5 | 10.4±1.7 | 16.0±5.4 | 14.6±4.1 | 0.001 | NS | NS |
| 18:3 n3 | 1.6±1.1 | 1.4±1.1 | 2.8±1.7 | 2.2±1.1 | 0.041 | NS | NS |
| 20:4 n6 | 15.3±3.0 | 16.4±4.0 | 12.0±2.2 | 11.9±3.5 | 0.002 | NS | NS |
| 20:5 n3 | 0.4±0.2 | 0.5±0.1 | 2.7±0.8 | 2.5±0.7 | 0.000 | NS | NS |
| 22:5 n3 | 0.2±0.1 | 0.2±0.1 | 1.0±0.1 | 1.0±0.1 | 0.000 | NS | NS |
| 24:1 | 0.4±0.3 | 0.3±0.1 | 1.1±0.5 | 1.0±0.4 | 0.000 | NS | NS |
| 22:6 n3 | 2.4±0.7 | 2.1±0.5 | 5.0±0.8 | 5.6±1.2 | 0.000 | NS | NS |
| Total n-3 PUFA | 4.7±2.0 | 4.6±1.4 | 10.8±2.5 | 11.2±3.0 | 0.000 | NS | NS |
| Total n-6 PUFA | 27.6±6.7 | 29.2±5.1 | 30.3±6.4 | 28.5±6.3 | NS | NS | NS |
| n-3/n-6 PUFA ratio | 0.2±0.1 | 0.2±0.1 | 0.4±0.2 | 0.4±0.2 | 0.000 | NS | NS |
| (b) Liver | |||||||
| 14:0 | 0.9±0.3 | 0.9±0.2 | 0.8±0.3 | 0.6±0.2 | 0.008 | NS | NS |
| 16:0 | 29.4±5.2 | 28.7±3.0 | 26.2±2.0 | 25.5±2.7 | 0.012 | NS | NS |
| 16:1 n7 | 6.3±2.7 | 6.1±2.2 | 5.2±2.0 | 4.5±1.3 | NS | NS | NS |
| 18:0 | 11.8±3.6 | 11.8±4.1 | 15.0±2.8 | 15.4±2.9 | 0.004 | NS | NS |
| 18:1b | 28.8±6.7 | 30.0±7.1 | 20.3±4.8 | 20.2±3.7 | 0.000 | NS | NS |
| 18:2 n6 | 5.8±3.3 | 5.7±2.0 | 10.2±4.3 | 9.7±2.8 | 0.000 | NS | NS |
| 18:3 n3 | 1.2±0.8 | 0.9±0.5 | 1.1±0.5 | 1.5±0.5 | NS | NS | NS |
| 20:4 n6 | 8.9±3.9 | 9.6±3.5 | 8.0±2.4 | 8.2±1.9 | NS | NS | NS |
| 20:5 n3 | 0.2±0.2 | 0.2±0.1 | 1.7±0.7 | 1.6±0.6 | 0.000 | NS | NS |
| 22:5 n3 | 0.2±0.1 | 0.2±0.1 | 0.1±0.0 | 0.1±0.1 | 0.012 | NS | NS |
| 24:1 | 0.3±0.2 | 0.3±0.2 | 1.1±0.4 | 1.1±0.2 | 0.000 | NS | NS |
| 22:6 n3 | 3.3±1.7 | 3.2±1.2 | 7.2±2.2 | 7.7±2.6 | 0.000 | NS | NS |
| Total n-3 PUFA | 5.0±2.8 | 4.7±1.6 | 10.2±2.5 | 11.2±3.7 | 0.000 | NS | NS |
| Total n-6 PUFA | 16.4±7.2 | 17.0±5.7 | 20.1±6.1 | 20.2±4.4 | NS | NS | NS |
| n-3/n-6 PUFA ratio | 0.29±0.1 | 0.3±0.1 | 0.58±0.3 | 0.60±0.3 | 0.001 | NS | NS |
Results represent means±S.D. (n=10). Totals include some minor components not shown.
a
Two-way ANOVA: lipid, significant influence of lipid source included in the treatment; ACN, significant influence of ACNs; L×ACN, interaction; NS, not significant (P>.05).
b
Contains n-9 and n-7 isomers.